Arkolith/Insider Trading/PTHS/Form 4

Francis Knuettel II

Chief Financial OfficerPelthos Therapeutics Inc. (PTHS) · full profile →Form 4 · filed Jul 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2025Conversion(C)10K$10.00$100K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2025Conversion(C)10K—$00
Jul 1, 2025Other(J)10K—$010K

Transaction Codes

C
Conversion of a derivative
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-25-001077) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML